AML (Acute Myeloid Leukemia),Leukemia FLT3‑ITD– Specific MRD Clearance Improves OS In FLT3-ITD+ AML Patients Nov 06, 2023
AML (Acute Myeloid Leukemia),Leukemia Quizartinib Extends OS In FLT3-ITD + AML Irrespective Of Allo-HCT In CR1 Oct 17, 2023
ALL (Acute Lymphoblastic Leukemia),CLL (Chronic Lymphocytic Leukemia),Leukemia PRIMCAR CD19-CAR T Cells Safety and Remission in R/R B-ALL Patients Oct 12, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Myeloablative Chemo-based Conditioning Shows Low Toxicity For Children With ALL Oct 11, 2023
CML (Chronic Myeloid Leukemia),Leukemia Optimal Dosing of Selumetinib and Azacitidine in Higher-Risk Chronic Myeloid Neoplasia Patients Oct 10, 2023
AML (Acute Myeloid Leukemia),Leukemia Venetoclax-FLAI Improves Survival in Intermediate/High-Risk AML Oct 09, 2023
CML (Chronic Myeloid Leukemia),Leukemia Asciminib Show Deep Responses In Patients With CML‑CP Oct 06, 2023
